Horovitz David, Meng Yifan, Joseph Jean V, Feng Changyong, Wu Guan, Rashid Hani, Messing Edward M
Department of Urology, University of Rochester Medical Centre; Rochester, NY, United States.
School of Medicine and Dentistry, University of Rochester; Rochester, NY, United States.
Can Urol Assoc J. 2017 Jul;11(7):E285-E290. doi: 10.5489/cuaj.4150. Epub 2017 Jul 11.
We sought to determine the value of obtaining preoperative urinary cytology when diagnostic workup of an upper tract mass is suspicious for upper tract urothelial carcinoma (UTUC), but biopsy fails to confirm the diagnosis.
Using billing code data, 239 patients were identified as having undergone radical nephroureterectomy (RNU) by 16 urologists from September 29, 1998 to July 31, 2015. Of this group, 19 adult patients had a presumed preoperative diagnosis of UTUC in a native kidney, at least three months of followup, no history of concurrent radical cystectomy with RNU, and negative/non-diagnostic tissue biopsy. These patients were divided into three groups: Group A had no urinary cytology taken (n=6); Group B had upper and/or lower tract cytology performed with neither positive nor atypical (n=7); Group C had upper and/or lower tract cytology performed with at least one positive or atypical (n=6).
Demographic information and diagnostic workup was similar between the groups, although Group A had more patients with a history of prior radical cystectomy for bladder cancer (p=0.02). One patient in Group B had benign tissue on final pathology. All patients in Groups A and C had malignancy on final pathology and overall, the three groups had similar rates of malignancy.
When a composite of clinical findings suggest UTUC, performing urinary cytology may not be necessary. A negative result in this setting should not be used to rule out UTUC, as this is often discordant with final pathology. A positive cytology result may help solidify the diagnosis when other findings are less clear.
当对上尿路肿块进行诊断性检查怀疑为上尿路尿路上皮癌(UTUC),但活检未能确诊时,我们试图确定术前进行尿细胞学检查的价值。
利用计费代码数据,确定了1998年9月29日至2015年7月31日期间16位泌尿科医生对239例患者实施了根治性肾输尿管切除术(RNU)。在这组患者中,19例成年患者术前被推测诊断为原发性肾UTUC,随访至少3个月,无同期行根治性膀胱切除术与RNU的病史,且组织活检结果为阴性/未确诊。这些患者被分为三组:A组未进行尿细胞学检查(n = 6);B组进行了上尿路和/或下尿路细胞学检查,结果均为阴性或非典型性(n = 7);C组进行了上尿路和/或下尿路细胞学检查,结果至少有一次为阳性或非典型性(n = 6)。
尽管A组有更多患者有膀胱癌根治性膀胱切除术史(p = 0.02),但三组之间的人口统计学信息和诊断性检查相似。B组有1例患者最终病理结果为良性组织。A组和C组的所有患者最终病理结果均为恶性,总体而言,三组的恶性率相似。
当综合临床检查结果提示UTUC时,可能无需进行尿细胞学检查。在这种情况下,阴性结果不应被用于排除UTUC,因为这往往与最终病理结果不一致。当其他检查结果不明确时,阳性细胞学结果可能有助于确诊。